Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1990 Jun;86:85–87. doi: 10.1289/ehp.908685

Metabolism and mutagenicity of isoprene.

P G Gervasi 1, V Longo 1
PMCID: PMC1567766  PMID: 2401275

Abstract

Liver microsomes of various rodents (mouse, rat, rabbit, and hamster) metabolize isoprene (2-methyl-1,3-butadiene) to the corresponding monoepoxides 3,4-epoxy-3-methyl-1-butene and 3,4-epoxy-2-methyl-1-butene. 3,4-Epoxy-3-methyl-1-butene (half-life 85 min) was found to be the main metabolite, although the stable 3,4-epoxy-2-methyl-1-butene was also formed (about 14-25% with respect to the main epoxide). The kinetic constants (Km and Vmax) for the formation of the major epoxide metabolite of isoprene were determined by gas-liquid chromatography. The minor epoxide was further epoxidized to the isoprene dioxide by the microsomes of all rodents studied. The Km and Vmax were determined and phenobarbital was found to be a good inducer for this epoxidation in all species. The mutagenic activity, using Salmonella typhimurium, and the chemical reactivity (alkylating power and half-life) of the epoxide metabolites of isoprene were investigated and compared to those of other structurally related epoxides. Isoprene and the monoepoxide intermediates of the isoprene biotransformation were not mutagenic in Salmonella typhimurium. However, the isoprene dioxide (2-methyl-1,2,3,4-diepoxybutane) was found to be mutagenic and have alkylating power towards nicotinamide, similar to the structurally corresponding 1,2,3,4-diepoxybutane. In conclusion, the metabolism of isoprene does not lead to the formation of mutagenic monoepoxide (in contrast to butadiene) but the formation of mutagenic and presumably carcinogenic isoprene diepoxide is possible, thereby a genotoxic effect of isoprene in rodents or other species cannot be ruled out.

Full text

PDF
85

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dahl A. R., Birnbaum L. S., Bond J. A., Gervasi P. G., Henderson R. F. The fate of isoprene inhaled by rats: comparison to butadiene. Toxicol Appl Pharmacol. 1987 Jun 30;89(2):237–248. doi: 10.1016/0041-008x(87)90044-5. [DOI] [PubMed] [Google Scholar]
  2. Del Monte M., Citti L., Gervasi P. G. Isoprene metabolism by liver microsomal mono-oxygenases. Xenobiotica. 1985 Jul;15(7):591–597. doi: 10.3109/00498258509045888. [DOI] [PubMed] [Google Scholar]
  3. Ehrenberg L., Hussain S. Genetic toxicity of some important epoxides. Mutat Res. 1981 Jan;86(1):1–113. doi: 10.1016/0165-1110(81)90034-8. [DOI] [PubMed] [Google Scholar]
  4. Gervasi P. G., Citti L., Del Monte M., Longo V., Benetti D. Mutagenicity and chemical reactivity of epoxidic intermediates of the isoprene metabolism and other structurally related compounds. Mutat Res. 1985 Apr-May;156(1-2):77–82. doi: 10.1016/0165-1218(85)90009-6. [DOI] [PubMed] [Google Scholar]
  5. Gervasi P. G., Citti L., Turchi G., Bellucci G., Berti G., Mastrorilli E., Tortello M. P. The metabolism of 1,3-cyclohexadiene by liver microsomal mono-oxygenase. Xenobiotica. 1982 Aug;12(8):517–526. doi: 10.3109/00498258209038930. [DOI] [PubMed] [Google Scholar]
  6. Hemminki K., Falck K., Vainio H. Comparison of alkylation rates and mutagenicity of directly acting industrial and laboratory chemicals: epoxides, glycidyl ethers, methylating and ethylating agents, halogenated hydrocarbons, hydrazine derivatives, aldehydes, thiuram and dithiocarbamate derivatives. Arch Toxicol. 1980 Dec;46(3-4):277–285. doi: 10.1007/BF00310445. [DOI] [PubMed] [Google Scholar]
  7. Longo V., Citti L., Gervasi P. G. Hepatic microsomal metabolism of isoprene in various rodents. Toxicol Lett. 1985 Dec;29(1):33–37. doi: 10.1016/0378-4274(85)90196-1. [DOI] [PubMed] [Google Scholar]
  8. Malvoisin E., Roberfroid M. Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica. 1982 Feb;12(2):137–144. doi: 10.3109/00498258209046787. [DOI] [PubMed] [Google Scholar]
  9. Mortelmans K., Haworth S., Lawlor T., Speck W., Tainer B., Zeiger E. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ Mutagen. 1986;8 (Suppl 7):1–119. [PubMed] [Google Scholar]
  10. Nelis H. J., Sinsheimer J. E. A sensitive fluorimetric procedure for the determination of aliphatic epoxides under physiological conditions. Anal Biochem. 1981 Jul 15;115(1):151–157. doi: 10.1016/0003-2697(81)90538-8. [DOI] [PubMed] [Google Scholar]
  11. Peter H., Wiegand H. J., Bolt H. M., Greim H., Walter G., Berg M., Filser J. G. Pharmacokinetics of isoprene in mice and rats. Toxicol Lett. 1987 Mar;36(1):9–14. doi: 10.1016/0378-4274(87)90035-x. [DOI] [PubMed] [Google Scholar]
  12. Wade D. R., Airy S. C., Sinsheimer J. E. Mutagenicity of aliphatic epoxides. Mutat Res. 1978 Nov;58(2-3):217–223. doi: 10.1016/0165-1218(78)90012-5. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES